Home
News
Regional News
Diseases
Disease News
Healthcare Policies
Conferences
COVID-19
Contact
More
Find the drug and healthcare news of the USA and Canada.
2023 | FDA Drug Approvals | US Pharma News | iPharmaCenter
CMS News | Medicare | Medicaid | 2023 | iPharmaCenter
CMS News | HHS | USA | Medicare, and Medicaid | Health insurance | Healthcare News
FDA News and Updates | US Pharma News | iPharmaCenter
2022 FDA Drug Approvals | US Pharma News | iPharmaCenter
Eisai's Leqembi received FDA approval for Alzheimer's | CMS coverage of Leqembi | ipharmacenter
Cigna | US Healthcare News | iPharmaCenter
US FDA Withdrawals | News | Blenrep was withdrawn from the US market | iPharmaCenter
COVID19 drug updates | FDA EMA approved COVID19 drugs
US FDA approved BMS Sotyktu (deucravacitinib) for moderate to severe plaque psoriasis |iPharmaCenter
Genzyme's Xenpozyme approved for Acid Sphingomyelinase Deficiency | iPharmaCenter
bluebird bio's $2.8 million gene therapy Zynteglo received FDA nod for beta-thalassemia
BMS' Breyanzi was approved for relapsed or refractory LBCL | News | FDA | iPharmacenter
Lilly's and Incyte's Olumiant approved for adults with severe alopecia areata
FDA approved two Opdivo based regimens as a 1L treatment for ESCC | FDA News | iPharmaCenter
FDA approved Kymriah for follicular lymphoma | Novartis | News | Cancer | | Updates | iPharmaCenter
FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK
~$10 bn acquisition paying off for Novartis as FDA approved Novartis' Leqvio
Myasthenia Gravis News | FDA and EMA approvals |
American College of Rheumatology (ACR) Convergence all-virtual annual meeting Updates
Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief
FDA approved Novartis Scembli for chronic myeloid leukemia
Biogen's Aduhelm received FDA approval for Alzheimer's disease; ICER criticized approval
GSK’s Jemperli received approval in Europe and the US for endometrial cancer
Gilead’s Trodelvy approved for triple-negative breast cancer in US
BMS’ and bluebird bio’s Abecma approved by US FDA; first CAR T cell therapy for multiple myeloma
FDA to review the accelerated approvals of Keytruda, Opdivo, and Tecentriq
Novartis’ blockbuster Entresto received the US FDA approval for a broader target population
US FDA approved BMS gene therapy Breyanzi
Merck and Bayer announced the US FDA approval for Verquvo
Expected best selling pharmaceutical products (drugs) in 2021
Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio
Biogen initiated Phase 4 trial to determine the efficacy of Spinraza in Zolgensma treated patients
REGENERON'S INMAZEB FIRST PRODUCT TO RECEIVE FDA APPROVAL FOR TREATING EBOLA VIRUS
CMS News
FDA approved GSK’s Nucala for Hypereosinophilic Syndrome
J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine
Pfizer received the approval of Xalkori for ALK-positive anaplastic large cell lymphoma
To strengthen the oncology portfolio, Merck collaborated with Seattle Genetics, and Gilead acquired
FDA approved Trelegy Ellipta for asthma, GSK’s triple therapy is now available for asthma and COPD
Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’
FDA approved Roche’s Gavreto for RET fusion-positive NSCLC
FDA extended emergency use authorization of Veklury to all hospitalized patients
FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test
FDA issued Emergency Use Authorization of Convalescent Plasma for COVID-19 treatment
Johnson and Johnson acquired Momenta Pharmaceuticals, aims to strength immunology profile
Amgen’s Kyprolis and Janssen’s Darzalex combination approved by the US FDA for multiple myeloma
Novartis Kesimpta approved for relapsing multiple sclerosis in the US
FDA says no to Gilead’s most anticipated product filgotinib
Genentech’s Enspryng approved for Neuromyelitis Optica Spectrum Disorder in the US